Brynn Levy, director of Columbia University's Clinical Cytogenetics laboratory and a clinical pathologist, is busy with a new multi-center grant to study how microarrays can diagnose prenatal diseases. GT's Ciara Curtin spoke with him about where cytogenetics and microarrays intersect. What follows are excerpts of their conversation, edited for space.
Genome Technology: You started out as a genetic counselor. Why did you move over to research?